Oxford joins Consortium to advance Quantum Drug Discovery
Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…
Summary : -The partnership between Oxford University and SEEQC promises to accelerate the use of quantum computing within pharmaceutical research in order…
Synopsis: –By 2025, the company aims to generate $60 billion in pharma sales, leaning mostly on existing medicines for growth until then,…
Synopsis: The test is a technological first in determining the metastatic status of a cancer without using prior insight of the primary…
Summary : –Nordic Nanovector ASA (OSE: NANOV) provides an update on the timeline for PARADIGME, its ongoing pivotal Phase 2b trial of Betalutin® (177Lu…
Summary : AstraZeneca has completed the transfer of its global rights to Eklira (aclidinium bromide), known as Tudorza in the US, and…
Summary : -Abbott, a global healthcare leader, announced that the US Food and Drug Administration (FDA) has approved new expanded magnetic resonance…
Summary : Clover Biopharmaceuticals, Ltd. (Clover; Stock Code: 2197.HK), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates and…
Summary: -Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today confirms the previously communicated timelines of its clinical trials…
Synopsis: Aptinyx Inc., a clinical-stage biopharmaceutical company, announced the initiation of a phase 2b study evaluating 50 mg QD of NYX-783 in…
Synopsis: AbbVie’s blockbuster hopeful Rinvoq notched a win in a tricky-to-treat group of Crohn’s disease patients. The trial studied the AbbVie drug…